Health Professional Radio - Podcast

Jim Palma, Executive Director at TargetCancer Foundation discusses a new clinical trial called TRACK (TargetRare Cancer Knowledge). Supported by Bayer and Foundation Medicine, TRACK provides rare cancer patients with access to genomic testing, personalized treatment recommendations and information via a virtual panel of rare cancer experts. This approach ensures that patients have access to this trial, even if they do not live near a clinical trial site and can socially distance due to COVID-19.